|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Dec 31, 2022
|
FY2022
10 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income (loss) | |||||
| Net Income / (loss) | |||||
| Adjustments to reconcile net income/(loss) to net cash provided by/(used in) operating activities: | |||||
| Depreciation and amortization expense | |||||
| Impairment Loss | |||||
| Stock-based compensation expense | |||||
| Deferred tax benefit | |||||
| Deferred tax expense / (benefit) | |||||
| Accrued income from long-term investments | |||||
| Provision for expected credit loss | |||||
| Gain on lease termination | |||||
| (Profit) / loss on sale of property and equipment | |||||
| Sundry balances written back | |||||
| Impairment in value of investments | |||||
| Change in fair value of forward purchase agreement put option liability | |||||
| Change in fair value of derivative warrant liabilities | |||||
| Gain on settlement of forward purchase agreement put option liability | |||||
| Loss on issuance of shares against accounts payable | |||||
| Unrealized exchange (gain) / loss | |||||
| Sundry balances written off | |||||
| Accounts receivable | |||||
| Prepaid expenses and other current assets | |||||
| Operating right-of-use assets | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued compensation and related benefits, current | |||||
| Other current liabilities | |||||
| Operating lease liabilities | |||||
| Other liabilities | |||||
| Net cash provided by/ (used in) operating activities | |||||
| Cash flows from investing activities | |||||
| Acquisition of property and equipment | |||||
| Sale of property and equipment | |||||
| Issuance of loans to affiliates | |||||
| Payments received for loans to affiliates | |||||
| Fixed Deposits placed with banks | |||||
| Proceeds from maturities of fixed deposits placed with banks | |||||
| Payment made towards investment in wholly owned subsidiary | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Net repayment of short term borrowings | |||||
| Payment of promissory note liability | |||||
| Payment of insurance financing liability | |||||
| Proceeds from long-term debt | |||||
| Repayment of long-term debt | |||||
| Payment of finance lease obligations | |||||
| Payment of deferred transaction costs | |||||
| Net changes in net shareholders’ investment | |||||
| Payment of FPA liabilities | |||||
| Proceeds from issuance of Class A ordinary shares, net of issuance cost | |||||
| Proceeds from issuance of subsidiary shares pursuant to MSOP agreement | |||||
| Payment for purchase of treasury shares | |||||
| Net cash (used in) / provided by financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net increase in cash and cash equivalents | |||||
| Cash and cash equivalents at the beginning of the year | |||||
| Cash and cash equivalents at the end of the year | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes, net of refunds | |||||
| Supplemental disclosure of non-cash investing and financing activities: | |||||
| Unpaid deferred transaction costs included in accounts payable and other current liabilities | |||||
| Equipment acquired under finance lease obligations | |||||
| Property and equipment purchase included in accounts payable | |||||
| Settlement of accounts payable through issuance of Class A ordinary shares to vendors | |||||
| Assumption of net liabilities from Business Combination | |||||
| Issuance of common stock to vendor in lieu future services | |||||
Loading...